Compare AGCO & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGCO | LNTH |
|---|---|---|
| Founded | 1990 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 4.2B |
| IPO Year | 1992 | 2015 |
| Metric | AGCO | LNTH |
|---|---|---|
| Price | $108.70 | $66.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $115.60 | $77.33 |
| AVG Volume (30 Days) | 697.6K | ★ 1.0M |
| Earning Date | 10-31-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.35% | N/A |
| EPS Growth | ★ 121.88 | N/A |
| EPS | ★ 5.02 | 2.39 |
| Revenue | ★ $10,049,100,000.00 | $1,525,933,000.00 |
| Revenue This Year | N/A | $0.01 |
| Revenue Next Year | $3.17 | $1.24 |
| P/E Ratio | ★ $21.74 | $27.84 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $73.79 | $47.25 |
| 52 Week High | $121.16 | $111.29 |
| Indicator | AGCO | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 57.74 | 72.55 |
| Support Level | $102.94 | $60.15 |
| Resistance Level | $107.88 | $64.40 |
| Average True Range (ATR) | 3.25 | 2.09 |
| MACD | 0.50 | 0.66 |
| Stochastic Oscillator | 74.73 | 94.44 |
Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.